Metabolised by CYP 2D6 and 3A4.

(To be edited, initial data ST OCT 04) Reversible acetylcholinesterase inhibitor used in mild to moderate Alzheimer. Metabolized by CYP 2D6 and 3A4. French list: use

Uneventful use reported in 1 patient with acute porphyria.